Manfred Donike Workshop 2020 Table of Contents

Manfred Donike Workshop 2020 Table of Contents

Recent Advances in Doping Analysis (28) – Proceedings of the 38th Cologne Workshop, 9.2. –14.2.2020 MANFRED DONIKE WORKSHOP 2020 TABLE OF CONTENTS PAGE LECTURES Marchand A, Ericsson M, Audran M, Fenaille F, Capdeville P, Martin L: EPO Biosimilars with unusual profiles: characterization and detection .................................... 13‐22 Heiland CE, Masquelier M: Sepharose gel beads: an effective technique for recombinant erythropoietin immuno‐ purification from blood ................................................................................................................ 23‐27 POSTER PRESENTATIONS Sigmund G, Geyer H, Goergens C, Thevis M: Prevalence of the imidazole derivatives naphazoline, oxymetazoline and xylometa‐ zoline in doping control samples ................................................................................................. 28‐31 Wicka M, Kaliszewski P, Grucza K, Stanczyk D, Drapala A, Konarski P, Zalewska Z, Siek P, Michalak D, Kwiatkowska D: Elimination profile of triamcinolone acetonide and its metabolite in human urine after multiple transdermal administrationed stimulants ........................................................... 32‐36 Barbán Duarte L, Martínez Brito D, Correa Vidal T, Montes de Oca Porto R: Trend analysis and decision making in the Havana Anti‐Doping Laboratory ............................. 37‐40 Rodriguez Fernandez A, Laffita D, López Castillo D, Terrero O, Montes de Oca R: Increase in the incidence of THC in urine samples of athletes in 2019 ....................................... 41‐45 Biasini GM, Donati F, Rutigliano L, de La Torre X, Botrè F: Proteomic analysis of biomarkers of red blood cells storage: towards the development of direct detection of autologous blood transfusion ............................................ 46‐51 Donati F, Botrè F, de La Torre X, Sian V, Biasini GM, Concetti L, Rutigliano L: Evaluation of the impact of genetic polymorphisms on basal values of human serum and urinary biomarkers: implications for anti‐doping analyses ................................................. 52‐58 RECENT ADVANCES IN DOPING ANALYSIS (28) ISBN 978-3-86884-046-9 Recent Advances in Doping Analysis (28) – Proceedings of the 38th Cologne Workshop, 9.2. –14.2.2020 PAGE Momobayashi A, Kageyama S, Okano M: Detection of homologous blood transfused erythrocytes by means of a two color fluorescence flow cytometric analysis ......................................................................................... 59‐62 Zhou X, He S, Zhang L, Shen L, He C: Administration Study of rEPOs circulated in China ................................................................................... 63‐67 He S, Zhou X, Zhang L, Shen L, He C: Troubleshooting for doping analysis of EPO ................................................................................ 68‐70 Somay Selbes Y, Onol S, Kacar T, Demirel AH, Aytekin S: Effects of protease inhibitors on stability of urine hCG and LH in doping analyses ................... 71‐73 Iannone M, Botrè F, de La Torre X: Direct and indirect detection of pseudo‐endogenous steroids in plasma .................................. 74‐79 Son J, Park JW, Lee SH: Multiple Biomarkers of Anabolic Agent Administration in Urine as Candidates for Doping Diagnosis ........................................................................................................................... 80‐84 Danila G, Pop A, Toboc A, Stan C: 7‐Keto‐DHEA – a case study .......................................................................................................... 85‐89 Geyer H, Fusshöller G, Haenelt N, Mareck U, Blatt C, Gougoulidis V, Hülsemann F, Piper T, Thevis M: The ratio 5aAdiol/E as indicator for the detection of testosterone doping in athletes with naturally low T/E – a case study .......................................................................................... 90‐93 Wen C, Liu X, Tianshuo Z, Jingzhu W: Isolation of boldenone and its metabolite in urine sample and further determination of the C/ C ratios by gas chromatographycombustion‐isotope ratio mass spectrometry ............. 94‐97 Mabusa I, Du Preez H, van der Merwe T: Proposed suppression of phentermine derivatization by concomitant medication: A GC‐MS case study and suggested solution ............................................................................. 98‐102 Kaewklum M, Kaewklum S, Dithayam S, Wilairat P, Kongpatanakul S: Separation and identification of regioisomers of fluoroamphetamine and fluorometh‐ amphetamine in doping control by gas chromatography‐mass spectrometry ...................... 103‐107 Stacchini C, Dima AP, de La Torre X, Mazzarino M, Botrè F: In vitro studies of the metabolic profile of different classes of SARMs using liquid chromatographic‐mass spectrometric techniques .................................................................. 108‐112 Songsaeng R, Saardpun N, Kusamran T, Kongpatanakul S: Method Development for Identification of Growth Hormone Releasing Peptides (GHRPs) in Doping Control by UFLC/MS‐IT‐TOF ....................................................................... 113‐117 RECENT ADVANCES IN DOPING ANALYSIS (28) ISBN 978-3-86884-046-9 Recent Advances in Doping Analysis (28) – Proceedings of the 38th Cologne Workshop, 9.2. –14.2.2020 PAGE Ahi S, Dubey S, Bhardwaj A, Sahu PL: Fast and sensitive detection of small peptides in human urine using liquid chroma‐ tography tandem mass spectrometry .............................................................................................. 118‐123 Berghes B, Radu M, Cristea CD, Toboc A, Stan C: Validation of HIF activating agents confirmation methods ......................................................... 124‐128 Grucza K, Wicka M, Drapala A, Konarski P, Stanczyk D, Michalak D, Kaliszewski P, Kwiatkowska D: Impact of various purity grades of acetonitrile and different mass spectrometry ionization methods on limits of detection of dopingsubstances by means of the “Dilute‐and‐Shoot” approach ............................................................................................................ 129‐133 Alechaga E, Terrero A, Monfort N, Ventura R: UHPLC‐HRMS multi‐screening method for doping control analyses in urine samples ........... 134‐138 de la Cal A, Espinosa P, Blázquez I, Fernández B, García L, de Pedraza L, Carreras D, Muñoz G: Solving problems with HILIC columns: Compounds with difficult chromatographic behavior ................................................................................................................................................ 139‐143 Fernández‐Álvarez M, Cuervo D, Baltazar‐Martins JG, Plata MDM, Muñoz‐Guerra JA, Lara B, Del Coso J, Muñoz G, Carreras D: Determination of tramadol and its metabolites in plasma by using liquid chroma‐ tography quadrupole time‐of‐flight mass spectrometry (LC‐Q‐TOF/MS) ................................. 144‐148 Cuervo D, Fernández‐Álvarez M, Baltazar‐Martins JG, Plata MDM, Muñoz‐Guerra JA, Lara B, Del Coso J, Muñoz G, Carreras D: Determination of tramadol and its metabolites in urine via accuratemass quadrupole time‐of‐flight (Q‐TOF) LC/MS ............................................................................................................ 149‐152 PRESENTATIONS ABSTRACTS ‐ LECTURES Gotzmann A: "Operation Aderlass”: Legislation as a cornerstone of anti‐doping .............................................. 153 Rossi F, Saugy M: Dried Blood Spots: Alternative matrix to deter and detect Tramadol abuse in road cycling competitions ........................................................................................................................ 154 Knoop A, Planitz P, Wuest B, Thevis M: Evaluation of cobalt in doping control samples: Discrimination of different cobalt sources .............................................................................................................................................. 155 Paßreiter A, Thomas A, Walpurgis K, Thevis M: First steps towards uncovering gene doping with CRISPR/Cas9 .................................................... 156 RECENT ADVANCES IN DOPING ANALYSIS (28) ISBN 978-3-86884-046-9 Recent Advances in Doping Analysis (28) – Proceedings of the 38th Cologne Workshop, 9.2. –14.2.2020 PAGE Coll S, Monfort N, Alechaga &, Matabosch X, Pérez‐Mañà C, Ventura R: Evaluation of the reporting level to detect betamethasone misuse in sports: additional studies after intranasal and intramuscular administrations ........................................ 157 Walpurgis K, Rubio A, Wagener F, Krug O, Knoop A, Görgens C, Guddat S, Thevis M: Elimination profiles of microdosed ostarine mimicking contaminated products ingestion .................................................................................................................................... 158‐159 Garzinsky A, Thomas A, Krug O, Thevis M: Exhaled breath in doping controls: characterization of SensAbues® sampling devices using an aerosol test generator ....................................................................................................... 160 Mongongu C, Ericsson M, Madi Moussa E, Audran M, Coudoré F, Marchand A, Buisson C: Quantitative determination of IGF‐I in dried blood using Volumetric Absorptive Micro‐sampling and Top‐down analysis with LC‐HRMS .......................................................... 161‐162 Miller G, Madrigal K, Lamm J, Husk J, Eichner D: Detecting growth hormone abuse in dried capillary blood spots: results from a large‐ scale field trial and a controlled administration study

View Full Text

Details

  • File Type
    pdf
  • Upload Time
    -
  • Content Languages
    English
  • Upload User
    Anonymous/Not logged-in
  • File Pages
    170 Page
  • File Size
    -

Download

Channel Download Status
Express Download Enable

Copyright

We respect the copyrights and intellectual property rights of all users. All uploaded documents are either original works of the uploader or authorized works of the rightful owners.

  • Not to be reproduced or distributed without explicit permission.
  • Not used for commercial purposes outside of approved use cases.
  • Not used to infringe on the rights of the original creators.
  • If you believe any content infringes your copyright, please contact us immediately.

Support

For help with questions, suggestions, or problems, please contact us